MedPath
NMPA Approval

Cefamandole Nafate for Injection

国药准字H20143231

March 1, 2024

Drug Information

注射用头孢孟多酯钠

注射剂

1.0g(按C18H18N6O5S2计)

化学药品

March 1, 2024

Company Information

Applicant Company

浙江省绍兴市柯桥区群贤路2003号1501室

Manufacturing Company

浙江省绍兴市越城区沥海街道南滨西路36号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用头孢孟多酯钠 - NMPA 批准文号 | MedPath